JPML Consolidates Effexor Birth Defect Actions In Pa.
Law360, New York (August 7, 2013, 1:49 PM EDT) -- The U.S. Judicial Panel on Multidistrict Litigation on Tuesday grouped nine product liability suits in Pennsylvania alleging Wyeth Pharmaceuticals Inc.'s depression and anxiety drug Effexor caused birth defects in children whose mothers used it during pregnancy.
The panel assigned the litigation to U.S. District Judge Cynthia M. Rufe in the Eastern District of Pennsylvania, saying she is best suited to hear the case since she already is overseeing multidistrict litigation with parallel claims involving Wyeth and its parent Pfizer Inc. over antidepressant Zoloft's alleged links to birth defects.
The panel found that the nine lawsuits pending in California, Illinois, Mississippi, Ohio...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!